Publications

• May 24, 2019
  

  Molecular Neuroimaging of the Dopamine Transporter (DAT) as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson Disease

• March 19, 2019
  

  The Importance of Drug Safety and Tolerability in the Development of New Immunosuppressive Therapy for Transplant Recipients

• February 23, 2019
  

  Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies

  Adedeji, Adeyemi O., Tony Pourmohamad, Yafei Chen, Jennifer Burkey, Catherine J. Betts, Susan J. Bickerton, Manisha Sonee, and James E. McDuffie. “Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies.” International Journal of Toxicology 38, no. 1 (February 2019): 12–22.

• February 16, 2019
  

  Recommendations for the Design of Therapeutic Trials for Neonatal Seizures

  Janet S. Soul, Ronit Pressler, Marilee Allen, Geraldine Boylan, Heike Rabe, Ron Portman, Pollyanna Hardy, Sarah Zohar, Klaus Romero, Brian Tseng, Varsha Bhatt-Mehta, Cecil Hahn, Scott Denne, Stephane Auvin, Alexander Vinks, John Lantos, Neil Marlow and Jonathan M. Davis for the International Neonatal Consortium.

• January 22, 2019
  

  The Turning Point for Clinical Research: Global Data Standardization

  Jauregui B, Hudson LD, BecnelLB, Navarro AlmarioE, FitzmartinR, PetavyF, Seigneuret N, Malone JK, Zhou FS, Galvez J, Jackson T, Harmon N, and R. Kush. The Turning Point for Clinical Research: Global Data Standardization.  Applied Clinical Trials, 2019 Jan 22